s.cabrera
TL2 · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 25 August 2025 · last posted 19h
89 posts, newest first. Showing up to 150.
-
When a dose reduction is the correct response to a side effect Replied, post #43 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #94 · Compounds › Retatrutide · 26 Jul 2026 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #86 · Practice › Interactions · 25 Jul 2026 · 10 likes I had written a reply contradicting post #84 and deleted it. Here is what survived. For anyone finding this later: the short answer on Antibiotics is that it depends on…
-
Cleaning a self-reported dataset and what you throw away — what changed since Replied, post #2 · Data & Tools › Datasets · 18 Jul 2026 · 2 likes Everything in the opening post holds. The case it does not cover is the one I have. How to contribute: if you have longitudinal data you want to add, the format is…
-
Seven-day rolling means and why weekly readings mislead Replied, post #40 · Outcomes › Progress reports · 16 Jul 2026 · 0 likes That is a cleaner way of putting what I was circling around.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #51 · Evidence › Journal club · 11 Jul 2026 · 0 likes I would rather this thread reach "we do not know" about SUSTAIN 6 than reach a confident answer that nobody can support when asked.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #14 · Clinical › Prescriber conversations · 7 Jul 2026 · 4 likes On post #12 — agreed on the reasoning, with one qualification. Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #101 · Start Here › How to Ask · 6 Jul 2026 · 3 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I am confident about the direction and…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #3 · Analytics › Impurities & related substances · 5 Jul 2026 · 17 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #101 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 3 likes Picking up post #99: that is the part I would want checked first. Typical suitability criteria are a replicate area relative standard deviation below about two per…
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #3 · Pharmacology › Receptor biology · 23 Jun 2026 · 17 likes Building on the opening post rather than restating it. GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce weight…
-
What to include when your question involves a chromatogram — one year on Replied, post #48 · Start Here › How to Ask · 23 Jun 2026 · 31 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Search filters: what is missing Replied, post #72 · Meta › Site feedback · 22 Jun 2026 · 10 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case. Adding a…
-
Racemisation and why it is invisible to a mass measurement Replied, post #118 · Analytics › Impurities & related substances · 15 Jun 2026 · 0 likes Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #66 · Safety › Contraindications · 8 Jun 2026 · 17 likes A history of pancreatitis appears in the cautions and the decision around it needs somebody who knows the history rather than a general rule. Not a strong opinion, just…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #15 · Analytics › HPLC & UHPLC · 8 Jun 2026 · 0 likes Two things can be true about Carryover at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
Cleaning a self-reported dataset and what you throw away Started this topic · Data & Tools › Datasets · 28 May 2026 · 37 likes Cleaning a self-reported dataset and what you throw away — setting out what I have, and where I think it stops being reliable. Collecting what is known about cleaning a…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #13 · Documentation › Doc review · 27 May 2026 · 25 likes The failure mode on draft on reconstitution arithmetic is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is…
-
Tracking a shortage from primary sources rather than rumour Replied, post #21 · Access › Shortages · 24 May 2026 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. That holds under the stated conditions and I have…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #51 · Compounds › Tirzepatide · 14 May 2026 · 4 likes Adding a data point of agreement rather than a data point.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #2 · Documentation › Doc review · 2 May 2026 · 14 likes Whatever the answer on draft on reconstitution arithmetic turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
A site rotation scheme that is easy enough to actually follow Replied, post #47 · Practice › Administration · 23 Apr 2026 · 17 likes Rotate on a fixed sequence rather than choosing each week. A sequence you follow beats a scheme you improvise, and it produces a record you can read back. Noting that…
-
Revisiting: Spike-and-recover accuracy for a peptide assay Started this topic · Analytics › Method validation · 9 Apr 2026 · 7 likes Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I was wrong about Spike-and-recover…
-
Follow-up: State-level differences that actually matter Replied, post #22 · Regional › North America · 5 Apr 2026 · 2 likes Post #19 is right about the mechanism and I think understates the practical bit. State-level differences looks different depending on whether you are reading the…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #74 · Sourcing › Regulatory · 2 Apr 2026 · 4 likes On post #70 — agreed on the reasoning, with one qualification. What I want from this compound being unapproved thread is the list of things that would need to be true…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #9 · Practice › Administration · 29 Mar 2026 · 23 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #48 · Compounds › Tirzepatide · 17 Mar 2026 · 27 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
CJC-1295 with and without DAC: what the modification does Replied, post #10 · Compounds › Secretagogues & GH axis · 9 Mar 2026 · 0 likes Post #8 and I disagree about the size of the effect, not about the direction. Storage: these are lyophilised short peptides and are generally reasonably stable dry and…
-
Grapefruit: why this class is not the class that cares Replied, post #21 · Practice › Interactions · 8 Mar 2026 · 12 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
A site rotation scheme that is easy enough to actually follow Replied, post #7 · Practice › Administration · 18 Feb 2026 · 6 likes Rotate on a fixed sequence rather than choosing each week. A sequence you follow beats a scheme you improvise, and it produces a record you can read back.
-
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Replied, post #3 · Compounds › Semaglutide · 2 Feb 2026 · 12 likes Answering the question the opening post raises rather than the one it answers. STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #3 · Compounds › Repair & healing peptides · 25 Jan 2026 · 11 likes This follows post #2 rather than contradicting it. Reframing Stability of BPC-157 slightly, because I think the disagreement is about the question rather than the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #73 · Access › International · 25 Jan 2026 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #67 · Practice › Side effects · 19 Jan 2026 · 27 likes Muscle cramps is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #44 · Meta › Site feedback · 14 Jan 2026 · 27 likes The arithmetic in post #43 is right; the assumption feeding it is the part to check. The bit of topic list that nobody enjoys is that the answer changes depending on…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #36 · Practice › Side effects · 5 Jan 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #8 · marked as the solution · Data & Tools › Datasets · 24 Dec 2025 · 8 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
The decimal-point error, and the habit that catches it Replied, post #116 · Practice › Reconstitution · 18 Dec 2025 · 1 like Adding the measurement that post #113 says would settle it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide…
-
Search filters: what is missing Replied, post #5 · Meta › Site feedback · 24 Nov 2025 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Not a bug, but worth saying: the moderation log is paginated at twenty-five entries…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #50 · Safety › Adverse events · 24 Oct 2025 · 6 likes Where an event resolved, saying how and how long it took is as useful as the event itself, and it is the part usually omitted. The reasoning is more useful than the…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #18 · Data & Tools › Calculators · 13 Oct 2025 · 2 likes Coming back to post #16, because the follow-up matters more than the original answer. Calculator has been discussed here with more heat than it deserves, mostly because…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #2 · Data & Tools › Calculators · 9 Oct 2025 · 13 likes Taking titration planner refuses seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
Realistic expectations for strength while losing weight quickly Replied, post #26 · Nutrition & Training › Resistance training · 6 Oct 2025 · 14 likes I read post #24 twice before replying, because I had assumed the opposite. Nothing here is medical advice and anybody with a relevant condition should have a programme…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #65 · Documentation › Doc review · 28 Sep 2025 · 3 likes Adding the measurement that post #64 says would settle it. Second maintainers matter. A single maintainer is a single point of failure and every document here that went…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #15 · Documentation › Doc review · 21 Sep 2025 · 22 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here. Speaking for…
-
Payment method and the leverage it gives you, ranked Replied, post #38 · Sourcing › Payments · 19 Sep 2025 · 20 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #115 · Evidence › Journal club · 26 Aug 2025 · 11 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Two people can…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #8 · Meta › Announcements · 25 Aug 2025 · 12 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 24 Aug 2025 · 16 likes Worth distinguishing the combination product from the two components bought separately and mixed. Those are different pharmaceutical objects and nothing published about…
-
Publishing an inconvenient result: a case study Replied, post #71 · Sourcing › Independent verification · 23 Aug 2025 · 0 likes Post #70 describes the usual case. This is about the unusual one. If someone has run publishing an inconvenient result properly I would rather read that than my own…
-
When a preprint is the best available evidence and we say so Replied, post #87 · Evidence › Preprints · 23 Aug 2025 · 4 likes Marking my place. If it changes for me I will come back and say so.
-
What pooling buys you and what it destroys Replied, post #8 · Evidence › Meta-analyses · 21 Aug 2025 · 0 likes The question underneath pooling buys is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #50 · Evidence › Journal club · 17 Aug 2025 · 3 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Are there stupid questions here? A staff answer, at length Replied, post #79 · Start Here › Welcome · 16 Aug 2025 · 16 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Revisiting: German, French and Dutch differences, compared Replied, post #58 · Regional › European Union · 13 Aug 2025 · 0 likes On German the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Travel coolers and how long they really hold Replied, post #31 · Devices › Cold chain · 3 Aug 2025 · 1 like Worth separating two things that post #29 runs together. Counterpoint on travel coolers, offered without confidence: the same observation is consistent with a much…
-
Managing an unplanned gap in supply — what changed since Replied, post #29 · Access › Shortages · 2 Aug 2025 · 33 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
-
Micronutrient status when intake falls substantially Replied, post #19 · Clinical › Bloodwork · 23 Jul 2025 · 0 likes No notes. Posting so the count is not one.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #8 · Wellbeing › Mental health · 20 Jul 2025 · 7 likes Reading this Anxiety thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Regression to the mean in progress reports Replied, post #33 · Research Methods › Statistics · 16 Jul 2025 · 27 likes Regression to the mean explains a large share of apparent improvements in anything selected for being extreme. It is not a statistical curiosity; it is the default…
-
What a documentation review can and cannot tell you Replied, post #20 · Sourcing › Independent verification · 1 Jul 2025 · 8 likes The version of documentation review that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Repeatability versus intermediate precision Replied, post #86 · Analytics › Method validation · 28 Jun 2025 · 0 likes Taking post #85 at face value and following it one step further. Precision has two levels worth distinguishing: repeatability within a run and intermediate precision…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #140 · Compounds › Cagrilintide & amylin analogues · 24 Jun 2025 · 10 likes Taking post #138 at face value and following it one step further. Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #44 · Evidence › Journal club · 18 Jun 2025 · 16 likes I changed my mind about CagriSema phase 2 combination paper after someone here asked me for the source and I could not produce one. That is worth saying out loud…
-
About the Contraindications category Replied, post #9 · Safety › Contraindications · 1 Jun 2025 · 0 likes No notes. Posting so the count is not one.
-
Follow-up: Documentation that appears only after payment Replied, post #87 · Sourcing › Red flags · 17 May 2025 · 28 likes A request rather than an answer: could whoever has the primary source for Documentation post it? I have seen the claim three times this month and each version had lost…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #10 · Practice › Dosing & titration · 3 May 2025 · 18 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #34 · Sourcing › Independent verification · 1 May 2025 · 14 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Certificates issued by the seller versus by a laboratory Replied, post #66 · Analytics › COA interpretation · 28 Apr 2025 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Albumin binding and how it produces a long half-life Replied, post #28 · Pharmacology › Pharmacokinetics · 23 Apr 2025 · 1 like Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
When "no data" is the complete and final answer Replied, post #152 · Compounds › Other compounds · 18 Apr 2025 · 18 likes Post #149 describes the usual case. This is about the unusual one. Compounds this community declines to help with, and why: there are specifics in the guidelines and…
-
Deamidation and the close-eluting pair it produces Replied, post #21 · Analytics › Impurities & related substances · 7 Apr 2025 · 0 likes What I can speak to on deamidation is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #121 · Compounds › Semaglutide · 28 Mar 2025 · 9 likes Answering the question post #117 raises rather than the one it answers. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #46 · Access › Pricing · 27 Mar 2025 · 0 likes Adding the measurement that post #43 says would settle it. Where somebody posts a comparison, the useful version states the date, the region and what was included. A…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #16 · Practice › Dosing & titration · 25 Mar 2025 · 28 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Retatrutide dose escalation in the published trials Replied, post #44 · Compounds › Retatrutide · 24 Mar 2025 · 8 likes Post #42 and I disagree about the size of the effect, not about the direction. Dose-response in the phase 2 obesity work was clear across the studied range, with no…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #16 · Sourcing › Vendor reports · 20 Mar 2025 · 19 likes Everything in post #13 holds. The case it does not cover is the one I have. The cost of a submission is worth stating. It is the main reason people do not do this and…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #37 · Evidence › Journal club · 11 Mar 2025 · 0 likes The arithmetic on SURMOUNT-OSA is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #107 · Compounds › Semaglutide · 15 Feb 2025 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #5 · Start Here › Welcome · 28 Jan 2025 · 0 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Identical chromatograms across two different lots Replied, post #81 · Sourcing › Red flags · 25 Jan 2025 · 32 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
[2026 update] New subcategory: rationale and scope Replied, post #110 · Meta › Announcements · 1 Jan 2025 · 9 likes Reporting rather than recommending, on New subcategory. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #72 · Compounds › Tirzepatide · 6 Dec 2024 · 21 likes Helpful, and short, which on this subject is harder than long.
-
Transporting a vial for a weekend away Replied, post #38 · Practice › Storage & stability · 7 Nov 2024 · 33 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Second pass at: Reimbursement variation across member states Replied, post #18 · Regional › European Union · 10 Oct 2024 · 31 likes Post #15 is the version of this I will quote in future. One addition. One caution on Reimbursement variation across member states: everything above assumes the…
-
The mass-error checker and its intended scope Replied, post #161 · Data & Tools › Calculators · 28 Jul 2024 · 8 likes Building on post #159 rather than restating it. Taking mass-error checker seriously for a moment rather than deflecting: the honest position is that the community has…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #117 · Compounds › Retatrutide · 24 Jul 2024 · 3 likes On post #115 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #22 · Practice › Dosing & titration · 7 Jul 2024 · 12 likes I read the earlier replies on Splitting a weekly dose twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
-
Assessing a warm arrival: the decision process — one year on Replied, post #87 · Sourcing › Logistics · 31 May 2024 · 8 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. That is the version I use. It may not be the version…